ClinicalTrials.gov
public full text
Public Domain
Nordic Pancreatic Cancer Trial (NorPACT) - 1
This study evaluate the additional effect of adding chemotherapy prior to resection of a pancreatic head malignancy. The patients will be randomized into two groups; surgery first (control group) and neoadjuvant chemotherapy (intervention). Primary endpoint is overall survival after resection
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Timing of Start of systemIc Treatment for Asymptomatic Metastasized Pancreatic Cancer#1137787
- Efficacy and Safety Study of PBI-05204 in Patients With Stage IV Metastatic Pancreatic Adenocarcinoma#831615
- Surgical Treatment of Pancreatic Metastases From Renal Cell Carcinoma#1057103
- A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy#880513
- Survival rate in patients with pancreatic cancer in Guilan province, Iran.#621025
Record · ID 878432
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive